Enter Domain Name:
damienbove.com: Drug Development Consultant and Drug Regulatory Consultant
Drug Development Consultancy and Regualtory Consultancy, we provide information and insights on FDA, EMEA, MHRA regulations and pharmaceutical biotechnology drug development

Drug Development Consultant and Drug Regulatory Consultant

Description: Drug Development Consultancy and Regualtory Consultancy, we provide information and insights on FDA, EMEA, MHRA regulations and pharmaceutical biotechnology drug development

Keywords: drug development, pharmaceutical funding, biotech funding, biotech development, development planning, Pharmaceutical, pharma, pharmacy, chemist, drug, medicine, NCE, Drug development, planning, development planning, testing, biotechnology, biotech, biopharma, biological, regulatory, regs, guidelines, agency, FDA, USA FDA, US FDA, food and drug administration, fedral drug administration, EMEA, European medicines evaluation agency, MHRA, UK drug agency, medicines and health regulatory authority, ICH, international commission on harmonisation, licensing, commercialisation, royalty, sales, sale, deal, clinical, human study, clinical study, clinical trial, pre-clinical, preclinical, non-clinical, nonclinical, animal study, animal testing, consultant, expert, advice, advisory, consulting, consult, new chemical entity, compound, chemical, active substance, API, active pharmaceutical ingredient, experiment, registration, NDA, New Drug application, CTX, CTA, clinical trial application, IND, investigational new drug, protocol, IB, investigators brochure, ethics committee submission, ethics, ethics submission, regulatory submission, biologic, bio, biotherapy, therapeutic agent, treatment, regulatory agency, drug agency, legal agency, NIH, national institute of health, GCP, good clinical practice, GLP, good laboratory practice, GMP, good manufacturing practice, ICH GCP, Phase 1, Phase1, PhaseI, phase II, Phase One, Phase2, phase 2, phase II, PhaseII, Phase two, phase 3, phase3, PhaseIII, phase III, phase three, Phase4, phase 4, phase IV, phaseIV, phase four, ethical study, efficacy study, clinical study, business consultant, consultancy, mentor, medical device, audit, GMP audit, GCP audit, GLP audit

Tags: damienbove, drug, consultant, development, regulatory, feed, free, strategy, recognised, expertise, rss, consultation, consultants, freestrategyconsultation, ida, featured, fda, consultancy, april, january, september, june, october, november, february, regulations, march, december, pain, comment, pharmaceutical, phase, guidance, chronic, emea, biotechnology, syndromes, new, information, july,

Damienbove.com

Content Revalency: Title: 80.00%   Description: 50.00%   Keywords: 14.88%  |  Document size: 34,398 bytes
More info: Whois - Trace Route - RBL Check
DAMIENBOVE.COM - Site Location
Country/Flag DE Germany
City/Region/Zip Code , ,
Organization 1&1 Internet AG
Internet Service Provider 1&1 Internet AG
DAMIENBOVE.COM - Domain Information
Domain DAMIENBOVE.COM   [ Traceroute  RBL/DNSBL lookup ]
Registrar 1&1 INTERNET SE 1&1 Internet SE
Registrar URL http://registrar.1and1.info
Whois server whois.1and1.com
Created 15-Mar-2007
Updated 09-Feb-2017
Expires 15-Mar-2018
Time Left 142 days 10 hours 23 minutes
Status clientTransferProhibited https://icann.org/epp#clientTransferProhibited clientTransferProhibited https://www.icann.org/epp#clientTransferProhibited
DNS servers NS-UK.1AND1-DNS.BIZ   217.160.81.3
NS-UK.1AND1-DNS.CO.UK   217.160.80.3
NS-UK.1AND1-DNS.COM   217.160.82.3
NS-UK.1AND1-DNS.ORG   217.160.83.3
DAMIENBOVE.COM - DNS Information
IP Address 82.165.210.171 ~ Whois - Trace Route - RBL Check
Domain Name Servers ns67.1and1.co.uk   217.160.80.173
ns68.1and1.co.uk   217.160.81.173
Mail Exchange mx01.1and1.co.uk   217.72.192.67
mx00.1and1.co.uk   212.227.15.41
Site Response Header
Response HTTP/1.1 200 OK
Server Apache
Date Sun, 10 Apr 2011 17:49:40 GMT
Content-Type text/html; charset=UTF-8
Cookie PHPSESSID=b2ad83342ffc8b1e276e9e958f22ed52; path=/